Skip to content

Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis

Comparison Between Conventional Ultrasound and Remote Ultraportable ulTrasound for Abdominal Examination in the Context of Viral Hepatitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06571981
Acronym
RUTH
Enrollment
102
Registered
2024-08-26
Start date
2024-11-01
Completion date
2025-12-31
Last updated
2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis, Teleradiology

Brief summary

Comparison of abdominal US exam in patients with viral hepatitis between ultraportable US with teleradiology capacities (TUP) versus conventional ultrasound (CUS)

Detailed description

Primary Objective The investigation seeks primarily to determine the performance of abdominal US examinations realized with TUP and CUS based on defined imaging criteria Secondary Objectives Evaluate satisfaction and comfort and reproducibility of use of the ultraportable US

Interventions

DEVICETUP ultraportable US with teleradiology capacities

Comparison of abdominal ultrasound examinations in an at-risk population diagnosed with viral hepatitis: Ultraportable ultrasound with teleradiology capacities (TUP) versus conventional ultrasound (CUS).

DEVICECUS conventional ultrasound

Comparison of abdominal ultrasound examinations in an at-risk population diagnosed with viral hepatitis: Ultraportable ultrasound with teleradiology capacities (TUP) versus conventional ultrasound (CUS).

Sponsors

Naik Vietti Violi
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed Consent signed by the subject * All adult patients with viral hepatitis for which an ultrasound is planned

Exclusion criteria

* Known or suspected non-compliance * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant, * Previous enrollment into the current study

Design outcomes

Primary

MeasureTime frameDescription
Comparison of TUP versus CUS for abdominal imaging in patients with viral hepatitis according to US LI-RADS categories ) for liver lesionsAt the end of interventionLI RADS categories No observation OR Only definitely benign observation(s) Observation(s) \< 10 mm in diameter, not definitely benign Observation(s) ≥ 10 mm in diameter, not definitely benign OR New thrombus in vein

Secondary

MeasureTime frameDescription
portal flow velocityAt the end of interventioncm/s
biliary tract / gallbladder abnormalitiesAt the end of interventionYes/No
lymph nodes presenceAt the end of interventionYes/No
free fluidAt the end of interventionYes/No
examination timeAt the end of interventionminutes
liver surface nodularityAt the end of interventionYes/No
caudate lobe dimensionsAt the end of interventioncm
liver visualization scoresAt the end of interventionno or minimal limitations; moderate limitations; severe limitations
audio qualityAt the end of interventionAdequate/Non Adequate
video qualityAt the end of interventionAdequate/Non Adequate
patient's satisfactionAt the end of interventionYes/No
agreement rates between reportsAt the end of interventionCategory 1: complete agreement/matching with teleradiologists reports; Category 2: minor discrepancy that would not impact patient management which included hedging terminology and ambiguous differences, for example fatty versus moderate fatty liver; Category 3: major discrepancy that would likely have an impact/change on patient management but would not lead to an adverse outcome for the patient; Category 4: major discrepancy that would impact patient management and lead to adverse outcomes for the patient.
focal lesionsAt the end of interventionYes/No

Countries

Switzerland

Contacts

Primary ContactNaïk Vietti Violi, MD
naik.vietti-violi@chuv.ch+41795560240
Backup ContactGiuseppe Gullo, MSc
giuseppe.gullo@chuv.ch+41213144444

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026